Skip to search formSkip to main contentSkip to account menu

SYR-322

Known as: SYR 322, SYR322 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

alogliptinalogliptin benzoate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin.
Alogliptin (codenamed SYR-322) is a recently approved anti-diabetic drug in Japan, which has been under clinical development… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)